English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > 医薬品企業の新しい多経路マーケティング戦略
カテゴリ
医薬品 (4955)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (182)
感染症 (351)
規制環境 (130)
後発医薬品 (134)
骨疾患 (37)
処方薬 (157)
神経疾患 (174)
精神疾患 (88)
製薬企業関連 (531)
創薬 (1523)
糖尿病 (192)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

医薬品企業の新しい多経路マーケティング戦略

New Multi-Marketing Channel Strategies

発行 Datamonitor
出版日 2009年08月 商品コード 99200
ページ情報 英文 57 pages
価格
US$ 3,800 換算 ¥ 306,622 (税抜) PDF by E-mail (Single User License)
US$ 9,500 換算 ¥ 766,555 (税抜) PDF by E-mail (Corporate Use License)


原文目次

Abstract

Introduction

The future of Pharma marketing lies in using new marketing channels such as social media intertwined with traditional marketing practices to create a multi-channel marketing mix. However, online brand promotion through social media is more effective for targeting patients than physicians, indicating direct marketing tactics to physicians through social media should be limited.

Scope of this research

  • Provides an overview of the reasons behind the need for new marketing channels
  • Explores the different channel mixes used to reach the pharma industry' s diverse customer base, both patients and doctors
  • Examines the use of online social media technology and uses in-depth case study analysis to examine the pros and cons of each marketing channel
  • Evaluates the future of online technology and how it can be used by Pharma marketing teams

Research and analysis highlights

Social media is an excellent communication medium for pharma companies wishing to interact with patients, incorporating both disease and product information. The informal relaxed setting suits the more emotive informational needs of patients.

The key for the industry now is to strike the right balance between use of new media tools and deciding which aspects of traditional marketing strategies should remain or can be modified to suit today' s marketing environment.

Using online technology such as eDetailing is the most effective online marketing tool for physicians, and can be used to create an effective closed-loop marketing strategy as part of a viable and sensible approach to successful physician marketing.

Key reasons to purchase this research

  • Understand why marketing practices in the pharmaceutical industry is changing
  • Access actionable recommendations through case study analysis on the appropriateness of eMedia strategies towards different target audiences.
  • Identify future models that Pharma companies could consider replicating going forward

Table of Contents

EXECUTIVE SUMMARY

  • Strategic scoping and focus
  • Datamonitor insight
  • Related reports

CHAPTER 2 EXAMINING THE NEED FOR A MULTI-CHANNELED MARKETING APPROACH

  • Traditional physician and patient marketing channels are becoming less effective
  • A multi-marketing channel approach is the way forward
    • Multi-channel marketing requires a tailored mix of traditional and novel media aimed at each target audience
  • Multi-channel marketing channels need to be considered in terms of targeted customers
    • New multiple-marketing channels need to be considered in terms of the healthcare professional targeted
    • New multiple-marketing channels need to be considered for patients too

WEB 2.0 TECHNOLOGY - A KEY COMPONENT OF MULTI-CHANNEL MARKETING

  • Pharma needs to be where its customers are - online
  • Web 2.0 technology enables Pharma to communicate with patients
    • YouTube - a underused communication tool
    • Pharma' s use of Facebook is still in its infancy
    • MySpace is not used by Pharma
    • Twitter - Pharma likes to Tweet!
    • Blogs are still a one-way communication method
    • Web 2.0 technology is not being used effectively as a promotional tool to target healthcare professionals
  • Opportunities for Pharma to create an integrated disease management program around its drugs
    • Google Health - personalized medicine will be the future
    • iPhone (smart-phone) applications - replacement educational incentive for reps seeking physician access
    • Wii Fit - a communication tool

BIBLIOGRAPHY

  • Publications and online articles
  • Datamonitor resources

APPENDIX

  • Search advertisement
  • Sponsored link
  • Web 2.0

TABLES

  • Table: Marketing approaches to key stakeholders
  • Table: Online physician and nurse communities, 2009
  • Table: Top 10 Pharma company websites visited by US physicians, 2008
  • Table: Brand sponsored patient communities
  • Table: Top 10 Big Pharma companies with the highest promotional spend, 2008
  • Table: Pharma companies with a presence on YouTube, 2009
  • Table: Big Pharma companies with corporate - employee Facebook pages (as of July 2009), 2009
  • Table: Pharma sponsored Facebook pages
  • Table: List of Pharma companies with Twitter accounts
  • Table: Pharma blogs - corporate and branded drug blogs sites currently in operation, 2009
  • Table: Top 10 iPhone health-related applications

FIGURES

  • Figure: Big Pharma companies ranked by their 2007 advertising budgets, 2006 - 07
  • Figure: Multi-channel marketing combines traditional and novel (web - based) approaches
  • Figure: Internal cross-functional teamwork necessary for multi-channel marketing strategy
  • Figure: Optimizing Pharma- physician communication channel strategies
  • Figure: An outline of the FDA' s draft guidelines on presenting risk information in prescription drug and medical device promotional material
  • Figure: The pros and cons of YouTube as a means for pharma companies of raising both disease and product awareness among patients
  • Figure: Johnson & Johnson' s YouTube page
  • Figure: The pros and cons of a pharma Facebook profile as part of Pharma' s patient marketing strategy
  • Figure: Novartis-sponsored patient advocate Facebook page by Marcia Strassman, 2009
  • Figure: Twitter, MySpace and Facebook audience retention rates
  • Figure: The pros and cons for pharma companies f of a Twitter account
  • Figure: Boehringer Ingelheim' s Twitter page user occupation and online behaviors
  • Figure: Alli connect - GlaxoSmithKline' s honest blogging webpage)
Back to Top